Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Dearden

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Blood|December 4, 2010
Stage C or not stage C...?Claire Dearden
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 28, 2002
Monoclonal antibody therapy of haematological malignanciesClaire Dearden
Hematology. American Society of Hematology. Education Program|December 17, 2008
Disease-specific complications of chronic lymphocytic leukemiaClaire Dearden
Blood|December 10, 2020
TCL1 and TCR collaborate to drive T-PLLClaire Dearden
British Journal of Haematology|December 17, 2010
Large granular lymphocytic leukaemia pathogenesis and managementClaire Dearden
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Alemtuzumab in peripheral T-cell malignanciesClaire Dearden
Hematology. American Society of Hematology. Education Program|December 6, 2015
Management of prolymphocytic leukemiaClaire Dearden
Best Practice & Research. Clinical Haematology|November 29, 2015
Hairy cell leukemiaClaire Dearden
Blood|April 5, 2014
CLLonal selection: survival of the fittest?Claire Dearden
Blood|December 22, 2022
It's a BRAF new world for hairy cell leukemiaClaire Dearden
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Blood|December 4, 2010
Stage C or not stage C...?Claire Dearden
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 28, 2002
Monoclonal antibody therapy of haematological malignanciesClaire Dearden
Hematology. American Society of Hematology. Education Program|December 17, 2008
Disease-specific complications of chronic lymphocytic leukemiaClaire Dearden
Blood|December 10, 2020
TCL1 and TCR collaborate to drive T-PLLClaire Dearden
British Journal of Haematology|December 17, 2010
Large granular lymphocytic leukaemia pathogenesis and managementClaire Dearden
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Alemtuzumab in peripheral T-cell malignanciesClaire Dearden
Hematology. American Society of Hematology. Education Program|December 6, 2015
Management of prolymphocytic leukemiaClaire Dearden
Best Practice & Research. Clinical Haematology|November 29, 2015
Hairy cell leukemiaClaire Dearden
Blood|April 5, 2014
CLLonal selection: survival of the fittest?Claire Dearden
Blood|December 22, 2022
It's a BRAF new world for hairy cell leukemiaClaire Dearden
Pageof 10